CMI boosts medical affairs capabilities with new specialty communications unit

CMI Media Group has launched a new Specialty Communications business unit to significantly expand its Medical Affairs capabilities, treating scientific communications as biopharma’s essential “third pillar” alongside commercial and clinical operations. Led by Group President Eugene Lee and Senior Vice President Mike Reynolds, the dedicated unit aims to modernize previously fragmented scientific exchanges by integrating therapeutic education earlier in the drug development lifecycle. Read the full article from FiercePharma here.